The Dok adaptor family of proteins binding to RasGAP, consisting of Dok-1 and Dok-2, are critical regulators in cell proliferation. These molecules are partners and/or substrates of different protein tyrosine kinases considered as oncoproteins. Here, we show that Dok-1 and Dok-2 are the major tyrosine-phosphorylated proteins associated to Tec, a protein tyrosine kinase expressed in T cells. Furthermore, we evaluate the effect of Dok-1 or Dok-2 on Tec-mediated signalling pathways in T cells. Here, we provide evidence that Dok-1 and Dok-2 proteins are involved in a negative feedback regulation of Tec via a downregulation of its tyrosine phosphorylation and downstream signalling pathways including the Ras pathway. Either Dok-1 or Dok-2 therefore represents a mean of potent retrograde control for protein tyrosine kinase signalling, and then possibly of tumor development.
Introduction
In patients with chronic myelogenous leukemia, the c-abl gene is translocated from chromosome 9 to chromosome 22 to produce a hybrid bcr-abl gene. A product of this chimeric bcr-abl gene, known as p210 bcr-abl , contains a high tyrosine kinase activity, which has been shown to be essential for the transforming activity of this chimera protein (Clarkson and Strife, 1993) . The expression of p210 bcr-abl in cell lines induces the tyrosine phosphorylation of two major substrates corresponding to the RasGAP-associated proteins: p62 dok-1 and p56
dok-2 /FRIP/DokR (Carpino et al., 1997; Di Cristofano et al., 1998) . Direct interactions between the protein tyrosine kinase (PTK) Bcr-Abl and its substrate Dok-1 have been reported (Bhat et al., 1998) . Dok-1 and Dok-2 proteins (downstream of tyrosine kinases) are members of a newly identified family of adaptor proteins phosphorylated not only by Bcr-Abl but also by other PTKs such as receptor tyrosine kinases (RTKs) or intracytoplasmic PTKs (Guy et al., 2002) . Dok-1 and Dok-2 have a similar structure, which contains a pleckstrin homology (PH) domain on the amino-terminus, with an adjacent phosphotyrosinebinding (PTB) domain and the carboxy-terminus part containing multiple tyrosine phosphorylation sites suitable for binding src-homology-2 (SH2) domains and some proline-rich regions suitable for binding SH3 domains. Different interaction domains of Dok adaptor molecules are involved in the binding with the PTKs: Dok PTB domains for some RTKs and the carboxyterminus part containing tyrosine and proline-rich regions for the intracytoplasmic PTKs. The relationships between the PTKs and the Dok adaptor molecules are not well known so far.
In vivo evidence suggests that these Dok adaptor molecules participate in signalling pathways that suppress cell proliferation. Dok-1 À/À mice have been generated (Yamanashi et al., 2000; Di Cristofano et al., 2001) . The comparison between cells derived from Dok-1 À/À or wild-type mice shows that Dok-1 is a negative regulator of cell proliferation for different hematopoietic lineages. The constitutive expression of Dok-2 in hematopoietic progenitor cells selectively reduces the number of T-cell precursors in the thymus, with a minor effect on myeloid and B-cell development (Gugasyan et al., 2002) . Dok-1 overexpression can mediate an inhibition of signalling pathways such as the extracellular signal-regulated 1/2 (ERK 1/2) activation in Tcell lines (Ne´morin et al., 2001) . The inhibitory mechanism currently proposed for the Ras/ERK pathway by Dok proteins corresponds to a recruitment of the Ras inhibitor RasGTPase-activating protein (Ras-GAP), via its SH2 domains, to the tyrosine-phosphorylated Dok proteins (Clarkson and Strife, 1993; Di Cristofano et al., 1998; Nelms et al., 1998; Jones and Dumont, 1999) . In this context, some aspects of the interactions of Dok proteins and PTKs in T cells have been analysed. Dok-1 and Dok-2 have been identified as substrates of the Src kinase family member Lck. This PTK can bind directly via its SH2 domain, the tyrosine-phophorylated Dok proteins (Ne´morin and Duplay, 2000) . Similar overall structures of PTKs are expressed in T cells, such as Tec kinases (Yang et al., 2000a; Miller and Berg, 2002 (Yang et al., 1999; Yoshida et al., 2000) . An interaction of Tec involving at least its SH2 domain with the tyrosine-phophorylated Dok-1 in B cells and myeloid cells has been reported (van Dijk et al., 2000; Yoshida et al., 2000; Liang et al., 2002) .
However, the ability of Dok proteins to associate with and regulate Tec in T cells has yet to be characterized. In order to identify Tec partners in T cells, Tec immunoprecipitates were performed in murine T-cell hybridomas ( Figure 1a) . A pervanadate treatment induces a large increase of the intracellular tyrosine phosphorylation level. Upon this treatment, only two phosphoproteins are detected by antiphosphotyrosine Western blot: 6 /point) were treated with 200 mM pervanadate for 5 min. Following the preparation of cell lysates, immunoprecipitations were performed as described previously (Nune`s et al., 1996) . The Tec immunoprecipitates (Tec IP) were analysed by Western blot analysis with antiphosphotyrosine antibody: P-Tyr (Upstate Biotechnology Inc., 4G10) (upper panel), anti-Dok-1 antibody (middle panel) or anti-Tec antibody (lower panel); these polyclonal antibodies have been described previously (Yang et al., 1999) (Yang et al., 2000b) . The construct bDNA 4 FlagTec (Tec) containing a wild-type full-length murine Tec cDNA tagged with the Flag epitope in the 5 0 end was generated by subcloning of pCDNAflagTec, described previously (Yang et al., 1999) , into the bDNA 4 vector. The Tec construct was cotransfected with different expression vectors coding for HA-tagged Dok proteins: Dok-1, Dok-2 or their mutants lacking the C-terminus part (Dok-1 DCter or Dok-2 DCter), as indicated. The construct bDNA 4 HADok1 (Dok-1), corresponding to the mouse Dok-1 tagged with HA epitope in the 5 0 end, was constructed by subcloning HADok in pCDNA3 (Yang et al., 1999) into the bDNA 4 expression vector. The deletion mutant of HA-tagged Dok-1 lacking the C-terminus part was amplified by polymerase chain reaction (PCR) using the following primers: 5 0 atgtacccatacgacgtcccagactacgctatggacggggctgtgatggag 3 0 (HA epitope tag) and 5 0 ctactagggaactgtcttcccctctg 3 0 for DCter Dok-1 (1-280 aa). The amplification products were cloned into the pGEM-T easy vector (Promega) and verified by sequencing. HA-tagged Dok-1 DCter was subcloned into the bDNA 4 vector using the NotI restriction site. The subcloning of HA-human Dok-2 fragment into pCDNA3 vector (pCDNAHADok2) was obtained by removal of this fragment from pCMV5-HADok2 (Di Cristofano et al., 1998) using BamHI restriction enzyme, blunting and subcloning in pCDNA3 using EcoRI and EcoRV restriction sites. The construct bDNA 4 HADok2 (Dok-2) was constructed by subcloning of pCDNAHADok2 into the bDNA 4 vector. The deletion mutant of HA-tagged Dok-2 lacking the Cterminus part (Dok-2 DCter) was amplified by PCR using the following primers: Tec itself and a 62 kDa protein corresponding to Dok-1, as shown by stripping following by reprobing with anti-Dok-1 and anti-Tec antibodies, respectively. Thus, an endogenous interaction between Tec and Dok-1 is detectable in T cells when these proteins are tyrosine phosphorylated. As reported previously in 293 cells (van Dijk et al., 2000) , an interaction of Dok-1 and Teckinase dead version can occur in the Jurkat leukemia Tcell line overexpressing these proteins (Figure 1b) . In these conditions, any induction of Dok-1 phosphorylation was detected. This phosphotyrosine-independent interaction of Dok with Tec was only detected in the overexpression system (Figure 1a versus b) , indicating that tyrosine phosphorylation of Dok is probably necessary to induce a stable association.
Most of the phosphorylable tyrosine residues in Dok-1 and Dok-2 are present in their carboxy-terminal part, which can be involved in the interaction with Tec. To investigate the mechanism of interaction between Tec and Dok in T cells, HA-tagged Dok proteins or Cterminus-deleted versions were overexpressed in combination with Flag-tagged Tec kinase into the Jurkat T-cell line. Immunoprecipitations of these tagged proteins were performed (Figure 1c) . Here, we show that only the full-length Dok proteins, but not their deleted C-terminus mutants, can be detected in the Tec immunoprecipitates, and Dok proteins are able to immunoprecipitate Tec. So Dok-1 and also Dok-2 can associate with Tec in T cells, as described in other cell systems (van Dijk et al., 2000; Yoshida et al., 2000) . It has been suggested that Tec is important to establish the scaffolding function of Dok-1, possibly thereby its phosphorylation (van Dijk et al., 2000; Yoshida et al., 2000; Liang et al., 2002) . However, these studies do not assess the direct role of Dok on Tec kinase activation. The autophosphorylation activity of Tec kinase is barely detectable by in vitro kinase assay (Yoshida et al., 2000) . We therefore evaluated Tec kinase activity by probing its tyrosine phosphorylation, which has been considered Jurkat T cells were transfected by electroporation and expression was conducted over 18 h. The pIL-2luc reporter plasmid (12 mg) was cotransfected with an empty vector (bDNA4) Tec (10 mg) in the presence or absence of wild-type Dok-1, Dok-2 or their deletion mutants (Dok-1 DCter or Dok-2 DCter) (15 mg) as indicated, together with pbactin-Rluc (2 mg) used to normalize the transfection efficiencies. Reporter plasmid-containing luciferase driven by the IL-2 promoter was assayed, as described previously (Yang et al., 1999) . The fold induction corresponds to the fold induction over the one obtained in the empty vector condition. Data shown are the average of three independent experiments7s.d. Overexpression of Tec and Dok proteins was controlled by Western blotting (data not shown). (c) Dok proteins' overexpression inhibits IL-2 promoter activity induced by the coligation of the TCR and CD28 receptor. The pIL-2luc reporter plasmid was cotransfected with an empty vector (bDNA4), Dok-1 or Dok-2 as indicated, together with pbactin-Rluc. Following electroporation, Jurkat cells were stimulated with antibodies against the TCR/CD3 complex (CD3 mAb: 289, 1/4000 dilution of ascites) and the CD28 costimulatory molecule (CD28 mAb: 248, 1/4000 dilution of ascites) or treated with PMA at 50 ng/ml and ionomycin at 2 mg/ml (P þ I) for 18 h. The fold inductions over the one obtained in the empty vector condition without stimulation have been calculated (values of the fold induction under CD3 þ CD28 condition ¼ 80 and under P þ I condition ¼ 2000 in the presence of the empty vector). The results were expressed as a percentage of fold induction relative to the value obtained in the empty vector condition. Data shown are the average of three independent experiments7s.d.
Dok-1 and Dok-2 proteins interact with Tec tyrosine kinase
A Gérard et al to be a good indicator of its catalytic activation (Yang et al., 2000a) . Tec, Dok-1 and its C-terminus-deleted mutant were overexpressed in Jurkat T cells and Tec immunoprecipitates were performed (Figure 2a ). For similar levels of Dok protein or its deleted mutant, a significant decrease of the Tec tyrosine phosphorylation level is detectable in the presence of Dok-1, but not of Dok-1 DCter. These observations suggest that the Dok proteins can both interact with Tec and inhibit its kinase activity, as probed by Tec tyrosine phosphorylation. This reduced tyrosine phosphorylation of Tec may result from either altered structural conformation of Tec due to Dok-binding, or by recruitment of a negative regulator. A more indirect mechanism cannot be excluded, involving an inhibition of a Tec activator such as an Src kinase family member (Shah and Shokat, 2002) . The results shown in Figure 2a suggest that Dok-1 is a regulator of Tec, by inhibiting its kinase activity. Tec induces cytokine gene transcription including IL-2 in Jurkat T cells (Yang et al., 1999 (Yang et al., , 2000b . In order to characterize the role of Dok adaptor proteins in Tecinduced functional events, we performed IL-2 promoter luciferase assays after overexpression of Tec, Dok proteins and their C-terminus-deleted mutants in Jurkat T cells (Figure 2b ). The presence of Dok-1 or Dok-2 blocks the IL-2 promoter activity induced by Tec. However, the deleted mutants of Dok do not regulate Tec function in this assay. Thus, Dok-1 or Dok-2 blocks Tec-induced IL-2 promoter activity. This Dok-mediated inhibition requires the C-terminus part of Dok proteins. Moreover, overexpression of Dok inhibited the IL-2 promoter activity, induced following activation of Tec kinase by TCR plus CD28 coligation (Figure 2c ). This inhibitory effect can be due to the Dok-mediated inhibition of Tec kinase activity and/or to the recruitment of the negative regulator of Tec-activated signalling pathways by the C-terminal domain of Dok-1 or Dok-2. Dok proteins are involved in the negative regulation of the Ras/ERK signalling pathway through their interaction with the RasGAP protein. Tec-induced functional events, such as IL-2 promoter activity induction, are highly sensitive to the inhibition of the Ras pathway using a dominant-negative form of Ha-ras: N17Ras (Figure 3a) . Using a mutant version of Dok-1 protein, DokY315F, unable to bind RasGAP (Figure 3b ), we tested whether Dok-mediated inhibition was dependent on its association with RasGAP (Carpino et al., 1997; Di Cristofano et al., 1998; Nelms et al., 1998; Jones and Dumont, 1999; Yoshida et al., 2000; Ne´morin et al., 2001; Gugasyan et al., 2002) . Wild-type and mutated versions of Dok-1 were phosphorylated by, and bound to Tec kinase, to the same extent (Figure 3c ). More importantly, Dok-1 Y315F inhibited Tec phosphorylation with the same efficiency as that of the wildtype Dok-1 protein (Figure 3d) . Moreover, Dok-1 Y315F is still capable of inhibiting Tec-induced IL-2 or Flag-tagged Tec (Tec) in the presence or not of a dominant-negative mutant of ras, Ha-ras N17 (N17Ras) into pEF-Bos expression vector (10 mg) has been included in the experiment, as described previously (Izquierdo et al., 1993) . Reporter plasmid-containing luciferase driven by the IL-2 promoter was assayed, as described in the legend of Figure 2 . Data shown are the average of three independent experiments7s.d. (b) HADok-1Y315F does not bind to RasGAP. Dok-1Y315F (Tyr315 to Phe) mutant was generated by site-directed mutagenesis using PCR and subcloned into the pSRapuromycin vector. Stable transfectant Jurkat T cells overexpressing HADok-1 wildtype or HADok-1Y315F were selected as described (Ne´morin et al., 2001) . Cells were stimulated with an anti-CD2 mAbs pair for 10 min. Dok-1 and Dok-2 proteins interact with Tec tyrosine kinase A Gérard et al promoter activity, albeit to a lesser extent than wild-type Dok-1 (Figure 3e ). The lower efficiency of Dok-1 Y315F to block the Tec function demonstrates that the RasGAP protein plays an important role in establishing a full inhibitory function of Dok in this Tec-induced IL-2 promoter activity. These observations suggest that Dok-1 and Dok-2 act as negative regulators of Tec functions in T cells by at least two mechanisms: direct inhibitory effect on Tec kinase and regulation of downstream pathways such as the Ras pathway.
Dok adaptor proteins are clearly the major tyrosine phosphoproteins interacting with Tec kinase in T cells (Figure 1a) . However, Dok-1 and Dok-2 can associate with different PTKs (van Dijk et al., 2000; Guy et al., 2002; Master et al., 2003) . However, the role of Dok proteins in the activity of these PTKs has not been directly assessed. Here, we show that Dok-1 is able to induce a decrease of the tyrosine phosphorylation state of Tec kinase (Figure 2a) . A recent report suggests that Dok-2 is a positive regulator of Abl kinase activity (Master et al., 2003) . However, in many PTK-induced signalling pathways downstream of Bcr-Abl, Src or the EGF receptor, Dok-1 or Dok-2 can antagonize the cellular transformation or leukemogenesis induced by these PTKs (Jones and Dumont, 1999; Di Cristofano et al., 2001; Shah and Shokat, 2002) . In T cells, both Dok-1 and Dok-2 are able to inhibit a potent activator of T-cell activation such as Tec (Figure 2 ). This study suggests that Dok proteins could mediate the downregulation of cell activation-promoting signals of the PTKs, involving either the downregulation of their catalytic activity or downstream events such as the Ras signalling pathway (Figure 3) . The assays performed in this work can be developed in high-throughput screening to identify new potent PTK inhibitors from chemical libraries. Expression of the Dok proteins will be a useful control for the inhibition of the PTKs in these experiments. Our results are in accordance with an elegant in vivo model showing that the presence of Dok-1 can antagonize the leukemogenesis induced by the Bcr-Abl oncoprotein (Di Cristofano et al., 2001) . Given all these observed negative regulatory activities of Dok-1 and Dok-2, it is tempting to propose that these molecules might be considered as tumor suppressors.
